Tuesday Jul 22
Kimmel Center Elects New Chairman of Board of Directors
The Kimmel Center is proud to announce that the Board of Directors of Kimmel Center, Inc. elected David P. Holveck as its Chairman, effective July 1, 2014.
Mon Jul 21, 2014
Endo International PLC Receives Consensus Recommendation of "Hold" from Analysts
Shares of Endo International PLC have been given an average recommendation of "Hold" by the twenty ratings firms that are presently covering the stock, Stock Ratings News reports .
Wed Jul 16, 2014
Endo International plc To Announce Second Quarter 2014 Financial Results On July 31, 2014
Please dial in 10 minutes prior to the scheduled start time. A simultaneous webcast of the call can be accessed by visiting www.endo.com .
Endo's Paladin Labs Reports Canadian Introduction Of Veregen
Paladin Labs Inc., a subsidiary of Endo International plc and a leading Canadian specialty pharmaceutical company, today announced the launch of VeregenA Ointment, 10%, a topical treatment for external genital and perianal warts in immunocompetent patients aged 18 years and over.
Thu Jul 10, 2014
Energy Transfer Equity LP (ETE), Liberty Interactive (Ventures group) ...
Jana Partners, managed by Barry Rosenstein capped a brilliant 2013 in the equity markets finishing strongly after delivering returns that met expectations.
Mon Jul 07, 2014
Raleigh's BDSI stock trading higher on good efficacy study, $10M infusion
The small drug developer received some of the best news in company history when it announced that a drug trial results showing that its product performed very well compared to a placebo.
Applied Clinical Trials
Endo and BioDelivery Sciences announce positive top-line results from ...
Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA buprenorphine in opioid-experienced patients with chronic pain /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc , and BioDelivery Sciences International, Inc. announced today positive top-line results from its ... (more)
Endo International plc, BioDelivery Sciences International Painkiller ...
Endo And Biodelivery Sciences Announce Positive Top-Line Results From The Phase III Clinical Trial Of BEMAA Buprenorphine In Opioid-Experienced Patients With Chronic Pain Pre-NDA meeting scheduled with FDA in July /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc , and BioDelivery Sciences International, Inc.
BioDelivery Sciences leaps on positive trial data
Secondary endpoints were also supportive of the treatment's efficacy. BioDelivery's stock is set to open above its all-time intraday high of $12.81 hit on June 18. Endo Pharma is a subsidiary of Endo International
Mon Jun 30, 2014
Endo International PLC Short Interest Down 9.8% in June
Shares of Endo International PLC saw a significant decrease in short interest in June.